Baidu
map

Nat Biotech:胚胎干细胞成功使失明小鼠恢复视力

2013-07-23 koo bio360

视网膜存在两种感光细胞:视锥细胞与视杆细胞,失去感光细胞是造成大量退行性疾病病患视力下降的“罪魁祸首”。 现在,伦敦大学学院科学家的使用实验鼠的胚胎干细胞,在人造视网膜帮助下,不仅在实验室培育出了眼部的感光细胞,而且将其移植进失明老鼠的眼部后让老鼠“重见光明”。这项刊登在《自然·生物技术》杂志上的最新研究,标志着人们向使用干细胞治疗失明又近了一步。 研究人员表示,最新研究的突破在于,他们已经证

视网膜存在两种感光细胞:视锥细胞与视杆细胞,失去感光细胞是造成大量退行性疾病病患视力下降的“罪魁祸首”。

现在,伦敦大学学院科学家的使用实验鼠的胚胎干细胞,在人造视网膜帮助下,不仅在实验室培育出了眼部的感光细胞,而且将其移植进失明老鼠的眼部后让老鼠“重见光明”。这项刊登在《自然·生物技术》杂志上的最新研究,标志着人们向使用干细胞治疗失明又近了一步。

研究人员表示,最新研究的突破在于,他们已经证明,可以将由胚胎干细胞获得的感光细胞植入成年老鼠眼部,这一研究为人类临床试验奠定了基础。他们将在 5 年内进行人体试验,试验如果取得成功,有望使医生们借用干细胞移植来改善成千上万名由于丧失感光细胞而罹患退行性眼病患者的视力。

研究人员从老鼠的胚胎中提取出了干细胞,并在实验室培育出的人造视网膜帮助下,将这些胚胎干细胞培育成了感光细胞。这一过程使得视杆细胞能发育出复杂的三维结构,而三维结构对于视杆细胞能正确“工作”非常重要。

随后,他们将大约 20 万个人造视杆细胞移植进患夜盲症的老鼠视网膜内,这些老鼠的视网膜内缺乏这种可以在低光环境下提供视力的视杆细胞,结果新细胞完全同复杂的视网膜组织结合在一起。

研究人员表示,经过多年研究,科学家们已经能很好地处理干细胞,并诱导它们发育成不同类型的成体细胞和组织。但迄今为止,视网膜的复杂结构一直被证明很难在实验室中再生。而这项最新技术很好地模拟了细胞正常的发育过程,这意味着科学家能在正确的发育阶段将细胞挑选出来并进行纯化,以确保移植成功。

研究人员计划下一步利用人类细胞对这一技术进行精炼,尽快开始人体试验。

Anai Gonzalez-Cordero, Emma L West, Rachael A Pearson, Yanai Duran, Livia S Carvalho, Colin J Chu, Arifa Naeem, Samuel J I Blackford, Anastasios Georgiadis, Jorn Lakowski, Mike Hubank, Alexander J Smith, James W B Bainbridge, Jane C Sowden& Robin R Ali. Photoreceptor precursors derived from three-dimensional embryonic stem cell cultures integrate and mature within adult degenerate retina. Nature Biotechnology, 21 July 2013; doi:10.1038/nbt.2643

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2014-05-23 cathymary
  2. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2013-08-31 sunylz
  3. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2014-02-08 ymljack
  4. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2014-01-27 shock_melon
  5. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2014-02-23 liye789132251
  6. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]
    2013-07-25 ailian1202
  7. [GetPortalCommentsPageByObjectIdResponse(id=1927595, encodeId=cc2e192e5958f, content=<a href='/topic/show?id=a59234e3b4' target=_blank style='color:#2F92EE;'>#Biotech#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=62, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3473, encryptionId=a59234e3b4, topicName=Biotech)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=226a143, createdName=cathymary, createdTime=Fri May 23 00:46:00 CST 2014, time=2014-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1916964, encodeId=f142191696488, content=<a href='/topic/show?id=4f26341994' target=_blank style='color:#2F92EE;'>#Bio#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3419, encryptionId=4f26341994, topicName=Bio)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=12de429, createdName=sunylz, createdTime=Sat Aug 31 13:46:00 CST 2013, time=2013-08-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1743595, encodeId=2aec1e43595e3, content=<a href='/topic/show?id=c92c42e3055' target=_blank style='color:#2F92EE;'>#复视#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=74, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=42730, encryptionId=c92c42e3055, topicName=复视)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c8d35156774, createdName=ymljack, createdTime=Sat Feb 08 14:46:00 CST 2014, time=2014-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1652077, encodeId=dbea16520e732, content=<a href='/topic/show?id=13d01e24509' target=_blank style='color:#2F92EE;'>#TEC#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17245, encryptionId=13d01e24509, topicName=TEC)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=852f24292001, createdName=shock_melon, createdTime=Mon Jan 27 05:46:00 CST 2014, time=2014-01-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1879580, encodeId=83d318e9580b2, content=<a href='/topic/show?id=3b2112532d8' target=_blank style='color:#2F92EE;'>#Nat#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=69, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12532, encryptionId=3b2112532d8, topicName=Nat)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e6f107, createdName=liye789132251, createdTime=Sun Feb 23 01:46:00 CST 2014, time=2014-02-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1315228, encodeId=c92413152280c, content=<a href='/topic/show?id=6fcc83e0554' target=_blank style='color:#2F92EE;'>#胚胎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83705, encryptionId=6fcc83e0554, topicName=胚胎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6393434, createdName=ailian1202, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1351197, encodeId=d676135119e46, content=<a href='/topic/show?id=37b083e182b' target=_blank style='color:#2F92EE;'>#胚胎干细胞#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=83718, encryptionId=37b083e182b, topicName=胚胎干细胞)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Jul 25 06:46:00 CST 2013, time=2013-07-25, status=1, ipAttribution=)]

相关资讯

世界爱眼日主题:眼睛健康以及平等获得治疗

  10月11日是“世界爱眼日”。世界卫生组织西太平洋地区委员会当天说,目前全球约有3900万名盲人,其中4/5只需接受适当的简单手术就能重见光明。   设在马尼拉的这个委员会说,白内障是造成人们失明的最主要原因,而治疗白内障只需简单手术更换浑浊的晶状体即可。这种手术简单高效,如今发达国家几乎没有人因白内障致盲,然而许多中低收入国家的白内障患者却因没有机会接受手术而失明,给患者本人、家庭和社会都

美国实施首例利用胚胎干细胞医治失明手术

来源:科技日报     据美国《华盛顿邮报》及《技术评论杂志》在线版7月15日消息,美国于近日正式进行了首例以人类胚胎干细胞医治渐进式失明患者的手术。这是美国食品和药物管理局(FDA)批准的第二起人类胚胎干细胞人体临床试验。而本次手术治疗备受重视,被认为是干细胞领域的重要里程碑,或将使饱受争议的人类胚胎干细胞研究证明其真实价值。   

Baidu
map
Baidu
map
Baidu
map